Potential use of heat shock protein 90 as a biomarker for the diagnosis of human diseases

被引:2
作者
Rivas-Macho, Ane [1 ]
Romeo, Maria V. [1 ,2 ]
Rackles, Elisabeth [3 ]
Olabarria, Garbine [1 ]
Falcon-Perez, Juan Manuel [3 ,4 ,5 ]
Berganza-Granda, Jesus [1 ]
Cortajarena, Aitziber L. [2 ,5 ]
Goni-de-Cerio, Felipe [1 ]
机构
[1] GAIKER Technol Ctr, Basque Res & Technol Alliance BRTA, Zamudio, Spain
[2] Ctr Cooperat Res Biomat CICbiomaGUNE, Basque Res & Technol Alliance BRTA, San Sebastian, Spain
[3] Ctr Cooperat Res Biosci CIC bioGUNE, Exosomes Lab, Basque Res & Technol Alliance BRTA, Bizkaia Technol Pk 801, Derio, Spain
[4] Ctr Invest Biomed Red enfermedades hepat & digest, Madrid, Spain
[5] Basque Fdn Sci, Ikerbasque, Bilbao, Spain
关键词
Heat shock protein; cancer; infectious diseases; biomarker; diagnosis; MOLECULAR-MECHANISM; SERUM BIOMARKER; LUNG-CANCER; HSP90; PHOSPHORYLATION; IDENTIFICATION; EXPRESSION; EXOSOMES; GRP94;
D O I
10.1080/14737159.2023.2246883
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
IntroductionThe heat shock protein 90 (Hsp90) is a protein involved in many different biological processes and especially in cell survival. Some of these functions require the participation of other biological molecules, so Hsp90 is a chaperone that takes part in many protein-protein interactions working as a critical signaling hub protein. As a member of the heat shock protein family, Hsp90 expression is regulated under certain environmental and/or stressful situations, therefore Hsp90 concentration can be monitored and linked to these effects.Areas coveredThis review discusses the Hsp90 expression in samples from individuals affected by different diseases (from infectious to cancer origin), and the biological consequences of these disorders, including the potential use of Hsp90 as a biomarker for the diagnosis of human diseases.Expert opinionThe potential of Hsp90 as a biomarker disease has been demonstrated in several studies in relation to infectious diseases and especially cancer. However, further research in this field is still needed, mainly to validate in statistically significant clinical studies that the detection of Hsp90 protein allows the diagnosis of some cancers at an early stage and also that it can act as a biomarker for monitoring the efficacy of their therapies.
引用
收藏
页码:875 / 884
页数:10
相关论文
共 76 条
[41]   Global proteomic analyses define an environmentally contingent Hsp90 interactome and reveal chaperone-dependent regulation of stress granule proteins and the R2TP complex in a fungal pathogen [J].
O'Meara, Teresa R. ;
O'Meara, Matthew J. ;
Polvi, Elizabeth J. ;
Pourhaghighi, M. Reza ;
Liston, Sean D. ;
Lin, Zhen-Yuan ;
Veri, Amanda O. ;
Emili, Andrew ;
Gingras, Anne-Claude ;
Cowen, Leah E. .
PLOS BIOLOGY, 2019, 17 (07)
[42]   Analysis of serum Hsp90 as a potential biomarker of β cell autoimmunity in type 1 diabetes [J].
Ocana, Gail J. ;
Sims, Emily K. ;
Watkins, Renecia A. ;
Ragg, Susanne ;
Mather, Kieren J. ;
Oram, Richard A. ;
Mirmira, Raghavendra G. ;
DiMeglio, Linda A. ;
Blum, Janice S. ;
Evans-Molina, Carmella .
PLOS ONE, 2019, 14 (01)
[43]   Structure and pro-toxic mechanism of the human Hsp90/PPIase/Tau complex [J].
Oroz, Javier ;
Chang, Bliss J. ;
Wysoczanski, Piotr ;
Lee, Chung-Tien ;
Perez-Lara, Angel ;
Chakraborty, Pijush ;
Hofele, Romina V. ;
Baker, Jeremy D. ;
Blair, Laura J. ;
Biernat, Jacek ;
Urlaub, Henning ;
Mandelkow, Eckhard ;
Dickey, Chad A. ;
Zweckstetter, Markus .
NATURE COMMUNICATIONS, 2018, 9
[44]   Heat shock proteins and their use as anticancer vaccines [J].
Parmiani, G ;
Testori, A ;
Maio, M ;
Castelli, C ;
Rivoltini, L ;
Pilla, L ;
Belli, F ;
Mazzaferro, V ;
Coppa, J ;
Patuzzo, R ;
Sertoli, MR ;
Hoos, A ;
Srivastava, PK ;
Santinami, M .
CLINICAL CANCER RESEARCH, 2004, 10 (24) :8142-8146
[45]   Hsp90-interacting Co-chaperones and their Family Proteins in Tau Regulation: Introducing a Novel Role for Cdc37L1 [J].
Peak, Stephanie L. ;
Gracia, Liam ;
Lora, Gabriella ;
Jinwal, Umesh K. .
NEUROSCIENCE, 2021, 453 :312-323
[46]   The cochaperone CHIP marks Hsp70-and Hsp90-bound substrates for degradation through a very flexible mechanism [J].
Quintana-Gallardo, Lucia ;
Martin-Benito, Jaime ;
Marcilla, Miguel ;
Espadas, Guadalupe ;
Sabido, Eduard ;
Maria Valpuesta, Jose .
SCIENTIFIC REPORTS, 2019, 9 (1)
[47]   Molecular mechanism and targeted therapy of Hsp90 involved in lung cancer: New discoveries and developments (Review) [J].
Rong, Biaoxue ;
Yang, Shuanying .
INTERNATIONAL JOURNAL OF ONCOLOGY, 2018, 52 (02) :321-336
[48]   Co-overexpression of Hsp90-β and annexin A1 with a significantly positive correlation contributes to the diagnosis of lung cancer [J].
Rong Biaoxue ;
Yang Shuanying ;
Li Wei ;
Ming Zongjuan ;
Cai Xiguang ;
Zhang Qiuhong .
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2014, 14 (08) :1067-1079
[49]  
Rong BX, 2014, AM J CANCER RES, V4, P874
[50]   Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study [J].
Rudd, Kristina E. ;
Johnson, Sarah Charlotte ;
Agesa, Kareha M. ;
Shackelford, Katya Anne ;
Tsoi, Derrick ;
Kievlan, Daniel Rhodes ;
Colombara, Danny V. ;
Ikuta, Kevin S. ;
Kissoon, Niranjan ;
Finfer, Simon ;
Fleischmann-Struzek, Carolin ;
Machado, Flavia R. ;
Reinhart, Konrad K. ;
Rowan, Kathryn ;
Seymour, Christopher W. ;
Watson, R. Scott ;
West, T. Eoin ;
Marinho, Fatima ;
Hay, Simon I. ;
Lozano, Rafael ;
Lopez, Alan D. ;
Angus, Derek C. ;
Murray, Christopher J. L. ;
Naghavi, Mohsen .
LANCET, 2020, 395 (10219) :200-211